Related references
Note: Only part of the references are listed.Distinguishing between resistance, tolerance and persistence to antibiotic treatment
Asher Brauner et al.
NATURE REVIEWS MICROBIOLOGY (2016)
Heterogeneous cell-cycle behavior in response to UVB irradiation by a population of single cancer cells visualized by time-lapse FUCCI imaging
Shinji Miwa et al.
CELL CYCLE (2015)
Lineage correlations of single cell division time as a probe of cell-cycle dynamics
Oded Sandler et al.
NATURE (2015)
Cell-cycle fate-monitoring distinguishes individual chemosensitive and chemoresistant cancer cells in drug-treated heterogeneous populations demonstrated by real-time FUCCI imaging
Shinji Miwa et al.
CELL CYCLE (2015)
Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance
Antonina V. Kurtova et al.
NATURE (2015)
Cyclotherapy: opening a therapeutic window in cancer treatment
Ingeborg M.M. van Leeuwen
Oncotarget (2015)
Contrasting Quiescent G0 Phase with Mitotic Cell Cycling in the Mouse Immune System
Michio Tomura et al.
PLOS ONE (2013)
Non-Darwinian dynamics in therapy-induced cancer drug resistance
Angela Oliveira Pisco et al.
NATURE COMMUNICATIONS (2013)
An evaluation of small-molecule p53 activators as chemoprotectants ameliorating adverse effects of anticancer drugs in normal cells
Ingeborg M. M. van Leeuwen et al.
CELL CYCLE (2012)
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen et al.
NATURE (2012)
Direct observation of mammalian cell growth and size regulation
Sungmin Son et al.
NATURE METHODS (2012)
The essence of yeast quiescence
Claudio De Virgilio
FEMS MICROBIOLOGY REVIEWS (2012)
Persistence: mechanisms for triggering and enhancing phenotypic variability
N. Q. Balaban
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
Metabolic status rather than cell cycle signals control quiescence entry and exit
Damien Laporte et al.
JOURNAL OF CELL BIOLOGY (2011)
Cancer Cells Cyclically Lose and Regain Drug-Resistant Highly Tumorigenic Features Characteristic of a Cancer Stem-like Phenotype
Kaijie He et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Metabolite-enabled eradication of bacterial persisters by aminoglycosides
Kyle R. Allison et al.
NATURE (2011)
Cell death assays for drug discovery
Oliver Kepp et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
How Darwinian models inform therapeutic failure initiated by clonal heterogeneity in cancer medicine
M. Gerlinger et al.
BRITISH JOURNAL OF CANCER (2010)
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sreenath V. Sharma et al.
CELL (2010)
A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
Alexander Roesch et al.
CELL (2010)
Cultured Human Tumour Cells May Be Arrested In All Stages of the Cycle During Stationary Phase: Demonstration of Quiescent Cells In G1, S and G2 Phase
B. Drewinko et al.
CELL PROLIFERATION (2010)
Robust Growth of Escherichia coli
Ping Wang et al.
CURRENT BIOLOGY (2010)
Targeting leukemic stem cells by breaking their dormancy
Marieke Alida Gertruda Essers et al.
MOLECULAR ONCOLOGY (2010)
Contribution of bone microenvironment to leukemogenesis and leukemia progression
F. Ayala et al.
LEUKEMIA (2009)
Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis
Sabrina L. Spencer et al.
NATURE (2009)
OPINION Non-genetic heterogeneity - a mutation-independent driving force for the somatic evolution of tumours
Amy Brock et al.
NATURE REVIEWS GENETICS (2009)
Cancer cells display intra- and interline variation profound following prolonged exposure to antimitotic drugs
Karen E. Gascoigne et al.
CANCER CELL (2008)
Visualizing spatiotemporal dynamics of multicellular cell-cycle progression
Asako Sakaue-Sawano et al.
CELL (2008)
Single-cell protein induction dynamics reveals a period of vulnerability to antibiotics in persister bacteria
Orit Gefen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A chemical method for fast and sensitive detection of DNA synthesis in vivo
Adrian Salic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Dynamic Proteomics of Individual Cancer Cells in Response to a Drug
A. A. Cohen et al.
SCIENCE (2008)
Nongenetic individuality in the host-phage interaction
Sivan Pearl et al.
PLOS BIOLOGY (2008)
Models, mechanisms and clinical evidence for cancer dormancy
Julio A. Aguirre-Ghiso
NATURE REVIEWS CANCER (2007)
The evolving concept of tumor microenvironments
Ezio Laconi
BIOESSAYS (2007)
Mechanisms of disease - Cancer stem cells
Craig T. Jordan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Hypoxia suppresses BCR/Abl and selects imatinib-insensitive progenitors within clonal CML population
S. Giuntoli et al.
LEUKEMIA (2006)
Target for cancer therapy: proliferating cells or stem cells
MV Blagosklonny
LEUKEMIA (2006)
Eradication of leukemia stem cells as a new goal of therapy in leukemia
F Ravandi et al.
CLINICAL CANCER RESEARCH (2006)
Repopulation of cancer cells during therapy: An important cause of treatment failure
JJ Kim et al.
NATURE REVIEWS CANCER (2005)
Bacterial persistence as a phenotypic switch
NQ Balaban et al.
SCIENCE (2004)
Rethinking synchronization of mammalian cells for cell cycle analysis
S Cooper
CELLULAR AND MOLECULAR LIFE SCIENCES (2003)
Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML)
YH Guan et al.
BLOOD (2003)
Sequential activation and inactivation of G2 checkpoints for selective killing of p53-deficient cells by microtubule-active drugs
MV Blagosklonny
ONCOGENE (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Retreatment of patients with the same chemotherapy: Implications for clinical mechanisms of drug resistance
S Cara et al.
ANNALS OF ONCOLOGY (2001)
Increased cellular hypoxia and reduced proliferation of both normal and leukaemic cells during progression of acute myeloid leukaemia in rats
PO Jensen et al.
CELL PROLIFERATION (2000)
Share Paper
